Published in Am Rev Respir Dis on February 01, 1991
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Mechanisms of virus induced exacerbations of asthma. Thorax (1997) 1.12
Inflammation-induced plasticity of the afferent innervation of the airways. Environ Health Perspect (2001) 1.00
ETB but not ETA receptor-mediated contractions to endothelin-1 attenuated by respiratory tract viral infection in mouse airways. Br J Pharmacol (1994) 0.95
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax (2005) 0.87
Airway Vagal Neuroplasticity Associated with Respiratory Viral Infections. Lung (2015) 0.87
Vagal Afferent Innervation of the Airways in Health and Disease. Physiol Rev (2016) 0.86
Time course of changes in ETB receptor density and function in tracheal airway smooth muscle during respiratory tract viral infection in mice. Br J Pharmacol (1996) 0.83
Virus-induced airway hyperresponsiveness--possible involvement of neural mechanisms. Am Rev Respir Dis (1991) 0.79
Parainfluenza 3-Induced Cough Hypersensitivity in the Guinea Pig Airways. PLoS One (2016) 0.76
Curative Effects of Suhuang Zhike Capsule on Postinfectious Cough: A Meta-Analysis of Randomized Trials. Evid Based Complement Alternat Med (2016) 0.75
Influence of respiratory tract viral infection on endothelin-1-induced potentiation of cholinergic nerve-mediated contraction in mouse trachea. Br J Pharmacol (1996) 0.75
Long-term intense exposure to grass pollen can mask positive effects of allergenic immunotherapy on non-specific bronchial hyperresponsiveness. Arch Med Sci (2014) 0.75
Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma? Thorax (1997) 0.75
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis (1976) 6.26
Bronchial hyperreactivity. Am Rev Respir Dis (1980) 4.77
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 4.64
An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer (1978) 3.82
The natural history of Hendra and Nipah viruses. Microbes Infect (2001) 3.77
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med (1988) 3.49
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30
Role of autonomic nervous system and the cough reflex in the increased responsiveness of airways in patients with obstructive airway disease. J Clin Invest (1967) 3.09
New method for perfusing bronchial arteries: histamine bronchoconstriction and apnea. J Appl Physiol (1966) 2.98
Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet (1985) 2.88
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping. J Virol (1981) 2.65
Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A (1999) 2.57
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol (1979) 2.48
Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology (1995) 2.41
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology (1999) 2.40
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.36
Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am Rev Respir Dis (1980) 2.31
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Selective paralysis of voluntary but not limbically influenced automatic respiration. Arch Neurol (1991) 2.27
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A (1997) 2.24
Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis (1987) 2.19
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax (2013) 2.17
Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16
O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol (1985) (1986) 2.16
Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A (1988) 2.15
Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol (1993) 2.14
Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis (1987) 2.09
Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res (1975) 2.02
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 1.96
Effect of histamine, serotonin, and acetylcholine on the peripheral airways. J Appl Physiol (1966) 1.95
Review of University of British Columbia Family Practice Resident Research Projects 1990-1997. Fam Med (1999) 1.94
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89
Assessment of upper airways obstruction. Br Med J (1972) 1.89
Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol (2000) 1.88
IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol (1999) 1.88
Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses (1987) 1.86
Exercise increases sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis (1981) 1.86
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest (1994) 1.85
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Bronchial hyperirritability in healthy subjects after exposure to ozone. Am Rev Respir Dis (1978) 1.82
Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis (1980) 1.81
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J Infect Dis (1971) 1.78
Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun (1987) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun (1988) 1.76
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Sympathetic versus parasympathetic nervous regulation of airways in dogs. J Appl Physiol (1971) 1.71
Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis (1990) 1.71
Active transport of Na+ and Cl- across the canine tracheal epithelium in vitro. Am Rev Respir Dis (1975) 1.71
Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol (1983) 1.67
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci (2001) 1.64
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther (1986) 1.62
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol (2001) 1.59
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59
Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax (2004) 1.57
Experimental asbestosis with four types of fibers: importance of small particles. Ann N Y Acad Sci (1965) 1.55
Resistance to breathing during exercise-induced asthma attacks. Am Rev Respir Dis (1970) 1.55
Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis (1990) 1.55
Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever. Br J Clin Pharmacol (1978) 1.55
Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med (2001) 1.54
Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method. Thorax (1999) 1.54
Mechanisms by which histamine stimulates rapidly adapting receptors in dog lungs. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.53
IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol (2001) 1.52
Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52
Influenza in patients with human immunodeficiency virus infection. Chest (1990) 1.50
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1994) 1.50
Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol (1985) (1985) 1.49
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler (2003) 1.49
Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea. J Pharmacol Exp Ther (1987) 1.48
Nine episodes of infective endocarditis in one patient--a new record. West J Med (1987) 1.48
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
"Normal-pressure" hydrocephalus. Relationship of clinical and radiographic findings to improvement following shunt surgery. JAMA (1976) 1.47
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Exopolysaccharide production by viridans streptococci in experimental endocarditis. Infect Immun (1984) 1.45
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J (2008) 1.44
Autonomic regulation of the airways. Annu Rev Med (1984) 1.42
Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest (1990) 1.42
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1989) 1.41
Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther (1988) 1.40
Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol (1980) 1.39